Singapore approves GSK's new cancer therapy for ovarian cancer - BSA bureau

7/4/2022 12:00:00 AM3 years 7 months ago

GSK's ovarian cancer drug approved in Singapore

For first-line and recurrent monotherapy maintenance treatment in advanced ovarian cancer GlaxoSmithKline (GSK) Singapore has announced that Health Sciences Authority has approved Zejula (niraparib)… [+1003 chars]

full article...